FMR LLC - RHYTHM PHARMACEUTICALS INC ownership

RHYTHM PHARMACEUTICALS INC's ticker is RYTM and the CUSIP is 76243J105. A total of 88 filers reported holding RHYTHM PHARMACEUTICALS INC in Q1 2019. The put-call ratio across all filers is - and the average weighting 1.3%.

Quarter-by-quarter ownership
FMR LLC ownership history of RHYTHM PHARMACEUTICALS INC
ValueSharesWeighting
Q3 2023$19,909,766
+72.1%
868,474
+23.8%
0.00%
+100.0%
Q2 2023$11,568,296
-53.6%
701,534
-49.8%
0.00%0.0%
Q1 2023$24,934,040
+10.8%
1,397,648
+80.8%
0.00%
-50.0%
Q4 2022$22,510,575
-33.0%
773,028
-43.6%
0.00%
-50.0%
Q3 2022$33,588,000
+1352.8%
1,370,948
+146.1%
0.00%
Q2 2022$2,312,000
-63.8%
556,994
+0.6%
0.00%
-100.0%
Q1 2022$6,381,000
+17.0%
553,867
+1.4%
0.00%
Q4 2021$5,452,000
+401.1%
546,320
+556.0%
0.00%
Q3 2021$1,088,000
-33.3%
83,2780.0%0.00%
Q2 2021$1,631,000
-7.9%
83,2780.0%0.00%
Q1 2021$1,771,000
+26.2%
83,278
+76.5%
0.00%
Q4 2020$1,403,000
+6.9%
47,178
-22.1%
0.00%
Q3 2020$1,313,000
-74.0%
60,598
-73.2%
0.00%
-100.0%
Q2 2020$5,042,000
+46.5%
226,0780.0%0.00%
Q1 2020$3,441,000
-85.4%
226,078
-78.0%
0.00%
-100.0%
Q4 2019$23,552,000
+2.9%
1,025,790
-3.3%
0.00%0.0%
Q3 2019$22,892,000
-13.1%
1,060,319
-11.5%
0.00%0.0%
Q2 2019$26,356,000
-39.5%
1,198,019
-24.6%
0.00%
-40.0%
Q1 2019$43,568,000
-4.1%
1,589,507
-5.9%
0.01%
-16.7%
Q4 2018$45,427,000
-4.2%
1,690,007
+4.0%
0.01%
+20.0%
Q3 2018$47,395,000
-17.0%
1,624,794
-11.0%
0.01%
-28.6%
Q2 2018$57,069,000
+121.3%
1,825,634
+40.9%
0.01%
+133.3%
Q1 2018$25,786,000
-31.9%
1,295,800
-0.5%
0.00%
-25.0%
Q4 2017$37,854,0001,302,6000.00%
Other shareholders
RHYTHM PHARMACEUTICALS INC shareholders Q1 2019
NameSharesValueWeighting ↓
MPM ASSET MANAGEMENT LLC 909,258$10,475,0003.58%
NEA Management Company, LLC 4,912,306$56,590,0001.64%
RA Capital Management 4,871,067$56,115,0001.22%
Pinz Capital Management, LP 148,475$1,710,0001.07%
Samsara BioCapital, LLC 345,293$3,978,0001.00%
Bell & Brown Wealth Advisors, LLC 117,400$1,352,0000.61%
Rock Springs Capital Management LP 1,237,026$14,251,0000.36%
ACT CAPITAL MANAGEMENT, LLC 27,500$317,0000.34%
Endurant Capital Management LP 105,792$1,219,0000.32%
Baker Brothers Advisors 4,125,062$47,521,0000.27%
View complete list of RHYTHM PHARMACEUTICALS INC shareholders